Inventor · disambiguated record
Stephanie Nouveau
Also filed as: NOUVEAU STEPHANIE · NOUVEAU STÉPHANIE
3 granted patents·9 pending applications·0 citations·filing 2000–2022
42Inventor score
Top patents by PatentIndex Score
12 records- 0153US12290375B2Predicting aging treatment outcomes based on a skin ageotypeOREAL·Filed 2022·Granted May 6, 2025·0 cites·18 claims
- 0251US2008159971A1Use of dhea or precursors or metabolic derivatives thereof as a depigmenting agentOREAL·Filed 2008·Application pending·0 cites
- 0349US12406771B2Predicting efficacies and improving skincare treatment outcomes based on responder/non-responder informationOREAL·Filed 2022·Granted Sep 2, 2025·0 cites·18 claims
- 0443US7351699B1Use of DHEA or precursors or metabolic derivatives thereof as a depigmenting agentOREAL·Filed 2000·Granted Apr 1, 2008·0 cites·25 claims
- 0540US2014044799A1Molecular signature of cutaneous pigmentary spots, associated with the organization of the extracellular matrixBERNERD FRANCOISE·Filed 2012·Application pending·0 cites
- 0640US2003003123A1Compositions and regime/regimen for treating the adverse signs of cutaneous skin agingFiled 2002·Application pending·0 cites
- 0740US2006204471A1Compositions and regime/regimen for treating the adverse signs of cutaneous skin agingOREAL·Filed 2006·Application pending·0 cites
- 0837US2003059451A1Use of orally administered dehydroepiandrosterone, precursors and derivatives thereof in order to improve the papery aspect of the skinFiled 2001·Application pending·0 cites
- 0933US2015307940A1Molecular signature of cutaneous pigmentary spots, associated with the extracellular matrixBERNERD FRANCOISE·Filed 2012·Application pending·0 cites
- 1032US2003124084A1Use of dehydroepiandrosterone and/or precursors or derivatives thereof to improve papery aspect of the skinFiled 2001·Application pending·0 cites
- 1130US2003083323A1Oral use of dehydroepiandrosterone and some of its derivatives as pigmentation regulatorsFiled 2001·Application pending·0 cites
- 1230US2003050293A1Use of dehydroepiandrosterone, its precursors and derivatives, by oral administration, as hydrating agents with direct actionFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Stephanie Nouveau files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →